Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00799682 · ClinicalTrials.gov registry record · Phase 4
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
A Phase 4 study, sponsored by Ophthalmic Consultants of Long Island.
- Completed
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT00799682 is a Phase 4 study that has completed, run by Ophthalmic Consultants of Long Island. The registered enrollment target is 56 participants.
The verdict
NCT00799682, a Phase 4 study, has completed, sponsored by Ophthalmic Consultants of Long Island.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if there is a difference in the ocular signs and symptoms of subjects' eyes using Xalatan® 0.005% versus Travatan Z® 0.004% based on the outcome of subject assessment and clinical assessment in patients with Ocular Hypertension or Glaucoma with mild to moderate dry eye at baseline in accordance with the Oxford Grading Scale.
Interventions
- DRUG Xalatan
- DRUG Travatan Z
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00799682
The ClinicalTrials.gov registry entry for NCT00799682 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ophthalmic Consultants of Long Island, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Xalatan is the first listed.
NCT00799682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00799682 about?
NCT00799682 is a clinical study titled "Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®". The purpose of this study is to determine if there is a difference in the ocular signs and symptoms of subjects' eyes using Xalatan® 0.005% versus Travatan Z® 0.004% based on the outcome of subject assessment and clinical assessment in patients with Ocular Hypertension or Glaucoma with mild to moder...
What is the current status of trial NCT00799682?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2008-10. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00799682?
The interventions under investigation include: Xalatan (DRUG), Travatan Z (DRUG).
Who is sponsoring clinical trial NCT00799682?
This trial is sponsored by Ophthalmic Consultants of Long Island, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.